Tesla and CureVac filed a joint patent on the technology. In August, Musk reviewed the project with Curevac while in Germany. By 2017, CureVac had received...

The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness...

additional companies such as Viacyte (part of Vertex), Nkarta, Capsida, Curevac, and others. CRISPR Therapeutics has drugs approved and in development...

CSL; 1904– ) CSPC Pharmaceutical Group (1992- ) CSPC Zhongrun (1989– ) CureVac (2000– ) CytRx (1985– ) Daiichi Sankyo (2005– ) Debiopharm (1979– ) Dechra...

patent on Moderna's mRNA vaccine technology, are ongoing. DNA vaccine CureVac "Moderna, Inc., 2023, Form 10-K Annual Report". U.S. Securities and Exchange...

or the Walvax COVID-19 vaccine used in Indonesia (and the now abandoned CureVac vaccine candidate, as well), do not have such requirements. In RNA therapeutics...

including Deutsche Post, Deutsche Telekom, Commerzbank, Lufthansa, and CureVac. In 2013, KfW agreed to help establish a Portuguese financial institution...

concerning the use of RNA and is a founder of the German biotechnology company CureVac. He created the initial technology used in RNA vaccines and has reportedly...

(€955 million). In July 2020, GSK acquired a 10% stake in German biotech company CureVac. In March 2018, GSK announced that it has reached an agreement with Novartis...

Oxford-AstraZeneca at €1.78; Johnson & Johnson at $8.50, Sanofi-GSK at €7.56, CureVac at €10, and Moderna at $18. In the same month, Israel ordered 8 million...